Partnering with X4 Pharmaceuticals, Inc. in its First FDA Approval in Rare Disease
Branding and series A launch for a biotechnology company pursuing vision-restoring engineered cell-based therapeutics.
A Landmark for Genome Editing
A clinical-stage debut for a precision player in the neuro space
Igniting global recognition of a landmark approval
A strong voice for gene therapy thought leadership
Introducing the first oral therapy for prostate cancer
